Related Experiment Video
Updated: Jan 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
A Cloud-based Risk Stratification Platform Cardiovascular Disease, Depression and Comorbidities
Insights
A new cloud-based platform integrates artificial intelligence (AI) models for accurate, cost-effective diagnosis of cardiovascular disease (CVD) and depression. This tool aids clinicians in identifying patients with both conditions for better management.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Healthcare
- Computational Psychiatry
Background:
- Co-occurrence of depression and cardiovascular disease (CVD) is clinically significant.
- Accurate identification of patients with comorbid depression and CVD is crucial for optimal management.
- Existing research lacks integrated tools for diagnosing both conditions simultaneously.
Purpose of the Study:
- To develop a cloud-based platform integrating AI models for diagnosing depression and CVD.
- To provide an easier, accurate, and cost-effective diagnostic solution.
- To facilitate clinical practice by enabling seamless AI model integration.
Main Methods:
- Development of a cloud-enabled computing unit utilizing REST architecture.
- Integration of AI algorithms and data exchange services.
- Implementation using Python 3, Java SDK 11, MySQL, and Payara Application Server on a Linux VM.
Main Results:
- A cost-effective, accurate, and efficient platform for risk stratification of depression and CVD.
- Seamless and transparent interfacing of AI models and applications for end-users.
- Successful hosting on a Linux Virtual Machine.
Conclusions:
- The developed platform represents a state-of-the-art solution for CVD and depression risk stratification.
- Cardiologists and psychiatrists can utilize this platform for improved patient identification and further examination.
- The integrated approach enhances the management of comorbid cardiovascular and depressive conditions.
Abstract:
There is strong clinical evidence that patients with depression have a high probability to exhibit cardiovascular disease (CVD) and vice versa. Thus, it is important to accurately identify these patients to provide optimal management of the comorbid conditions. Although the existing literature focuses on the development of artificial intelligence (AI) models for the diagnosis of CVD and/or depression, there is not currently any reported tool or system which integrates such models for clinical practice. In this work, we present a cloud-based platform to enable the easier, accurate, and cost-effective diagnosis of CVD and depression. The cloud-based platform is an integrated cloud-enabled computing unit that provides the execution of artificial intelligence computing algorithms along with data exchange services by utilizing the REST (Representational State Transfer) architecture. The platform enables the seamless and transparent interfacing of AI models and applications for the end-users. During the development a variety of state-of-the-art technologies and architectural models were integrated through a Payara Application Server, the Python programming environment (version 3) and a MySQL database server. Java SDK 11 was used for developing the full-stack API of the user interfaces and the back-end logic including the REST interfaces. The platform is hosted on a Linux Virtual Machine (VM). The development resulted in a cost-effective, accurate and efficient tool for the risk stratification of depression and CVD.Clinical Relevance- This is a state-of-the-art cloud-based platform for the risk stratification of CVD and depression. Example: Cardiologists and psychiatrists can use this platform to identify patients with CVD and depression and then prescribe more detailed examinations.
More Related Videos
Related Concept Videos
Depression: Overview
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

